Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Heart Disease
100%
Cesarean Section
55%
Vaginal Birth after Cesarean
47%
Cardiology
38%
Odds Ratio
37%
Pregnancy
34%
Cardiovascular Disease
30%
Heart Failure
24%
Maternal Age
21%
Obstetrics
20%
Gestational Age
19%
Cardiac Dysrhythmia
19%
Persistent Truncus Arteriosus
17%
Adverse Outcome
16%
Premature Labor
16%
Clinical Management
15%
Uterine Rupture
15%
Health Care Cost
12%
Pre-Eclampsia
12%
Thromboembolism
12%
Aortic Stenosis
11%
Pulmonary Hypertension
11%
Eisenmenger's Syndrome
11%
Maternal Morbidity
11%
Intrauterine Growth Retardation
11%
Maternal Mortality
10%
Ventricular Tachycardia
9%
Cardiovascular Risk
9%
Hypertrophic Cardiomyopathy
9%
Twin Pregnancy
9%
Hypoplastic Left Heart Syndrome
9%
Fetus Lung Maturity
9%
Lecithin-Sphingomyelin Ratio
9%
Respiratory System Disease
9%
Patient Safety
9%
Prematurity
9%
Stenosis
9%
Clinician
9%
Peripartum Cardiomyopathy
9%
Echocardiography
9%
Right Ventricle
9%
Herpes Simplex
9%
Cost-Effectiveness Analysis
9%
Prosthetic Valve Thrombosis
9%
Aortic Disease
9%
Retrospective Cohort Study
9%
Newborn Death
9%
Aortic Dissection
9%
Caesarean
8%
Respiratory Distress Syndrome
8%
Keyphrases
Vaginal Birth
19%
Preeclampsia
19%
Disease Data
19%
During Pregnancy
15%
Pregnant Women
13%
Heart Disease
13%
Adjusted Odds Ratio
12%
Uterine Rupture
11%
Clinical Risk Factors
11%
Pregnancy Outcome
10%
Maternal Morbidity
10%
Cardiovascular Disease
10%
Gestational Surrogacy
9%
Unipolar Depression
9%
Treatment Options
9%
Mechanical Aortic Valve
9%
Late Preterm
9%
Aortic Valve Thrombosis
9%
Adverse Outcomes
9%
Term Infants
9%
Urban Institutions
9%
Adverse Neonatal Outcome
9%
Non-pharmacological Treatment
9%
Uteroplacental Doppler
9%
Maternal Complications
9%
Ventricular Arrhythmia
9%
Longitudinal Assessment
9%
Hypertension Outcomes
9%
Angiogenic Factors
9%
21st Century
9%
Late Preterm Infant
9%
Prematurity
9%
Peripartum Cardiomyopathy
9%
Predictive Value
9%
Advanced Countries
9%
Eisenmenger Syndrome
9%
Depression during Pregnancy
9%
Cost-effectiveness Analysis
9%
European Society of Cardiology
9%
Electrocardiographic Monitoring
9%
Aortic Dissection
9%
Thoracic Aortic Disease
9%
Pregnancy Disorders
9%
Cardiac Disease
9%
Third Trimester
7%
Placental Growth Factor (PlGF)
7%
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
7%
Beta-blockers
7%
Adverse Cardiac Events
7%
Preterm Birth
6%
